Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larissa Ouro-Gnao

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scientific Reports|February 15, 2013
Copper prevents amyloid-β(1-42) from forming amyloid fibrils under near-physiological conditions in vitroMatthew Mold, Larissa Ouro-Gnao, Beata M Wieckowski, et al.
Hepatology Communications|January 8, 2020
A Microphysiological System for Studying Nonalcoholic SteatohepatitisTomasz Kostrzewski, Paloma Maraver, Larissa Ouro-Gnao, et al.
World Journal of Gastroenterology|January 28, 2017
Three-dimensional perfused human <i>in vitro</i> model of non-alcoholic fatty liver diseaseTomasz Kostrzewski, Terri Cornforth, Sophie A Snow, et al.
Mabs|April 29, 2020
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodiesMartin J Scott, Amanda Jowett, Martin Orecchia, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scientific Reports|February 15, 2013
Copper prevents amyloid-β(1-42) from forming amyloid fibrils under near-physiological conditions in vitroMatthew Mold, Larissa Ouro-Gnao, Beata M Wieckowski, et al.
Hepatology Communications|January 8, 2020
A Microphysiological System for Studying Nonalcoholic SteatohepatitisTomasz Kostrzewski, Paloma Maraver, Larissa Ouro-Gnao, et al.
World Journal of Gastroenterology|January 28, 2017
Three-dimensional perfused human <i>in vitro</i> model of non-alcoholic fatty liver diseaseTomasz Kostrzewski, Terri Cornforth, Sophie A Snow, et al.
Mabs|April 29, 2020
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodiesMartin J Scott, Amanda Jowett, Martin Orecchia, et al.
Pageof 1